Product Profile of Metadoze Ipr

Biocon is a fully integrated healthcare company that delivers innovative biopharmaceutical solutions. They present metadoze ipr.

• Composition of metformin 850 mg tablets with ipr [immediate and patterned release technology]

• In the treatment of type ii diabetes mellitus

• Used as a single drug or in combination with other drugs e.G. Glimepiride, pioglitazone, etc. To control blood glucose levels

• It incorporates a unique technology which enables immediate and sustained release of metformin.

• This not only makes metformin longer acting, but also improves absorption and reduces side effects.